Noteworthily, they also pointed out that in addition to HIF-1α, the correct phosphorylation of wild-type p53 in EBV+ cancer cells also to a great extent dictated the efficiency of lytic induction therapy [56]. The gene discussed is HIF1A; the disease is cancer.